{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:35:53Z","timestamp":1787315753052,"version":"build-2736575974"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14082-3","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T16:54:21Z","timestamp":1744217661000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Role of MRE11 in DNA damage repair pathway dynamics and its diagnostic and prognostic significance in hereditary breast and ovarian cancer"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9262-925X","authenticated-orcid":false,"given":"Bhoomi","family":"Tarapara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7265-2839","authenticated-orcid":false,"given":"Franky","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"issue":"3","key":"14082_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.5306\/wjco.v13.i3.209","volume":"13","author":"R Mehrotra","year":"2022","unstructured":"Mehrotra R, Yadav K. Breast cancer in India: Present scenario and the challenges ahead. World J Clin Oncol. 2022;13(3):209\u201318.","journal-title":"World J Clin Oncol"},{"issue":"6","key":"14082_CR2","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10552-021-01428-y","volume":"32","author":"JA McDonald","year":"2021","unstructured":"McDonald JA, Rao R, Gibbons M, Janardhanan R, Jaswal S, Mehrotra R, Pandey M, Radhakrishnan V, Ramakant P, Verma N, et al. Symposium report: breast cancer in India-trends, environmental exposures and clinical implications. Cancer Causes Control. 2021;32(6):567\u201375.","journal-title":"Cancer Causes Control"},{"issue":"6","key":"14082_CR3","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s12282-020-01148-2","volume":"28","author":"R Yoshida","year":"2021","unstructured":"Yoshida R. Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis. Breast Cancer. 2021;28(6):1167\u201380.","journal-title":"Breast Cancer"},{"key":"14082_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.568786","volume":"10","author":"MSN Kadri","year":"2020","unstructured":"Kadri MSN, Patel KM, Bhargava PA, Shah FD, Badgujar NV, Tarapara BV, Patel PS, Shaikh MI, Shah K, Patel A, et al. Mutational Landscape for Indian Hereditary Breast and Ovarian Cancer Cohort Suggests Need for Identifying Population Specific Genes and Biomarkers for Screening. Front Oncol. 2020;10: 568786.","journal-title":"Front Oncol"},{"key":"14082_CR5","doi-asserted-by":"crossref","unstructured":"Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Goggins M, Hutton ML et al: Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021, 19(1):77\u2013102.","DOI":"10.6004\/jnccn.2021.0001"},{"key":"14082_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.629266","volume":"11","author":"LY Li","year":"2020","unstructured":"Li LY, Guan YD, Chen XS, Yang JM, Cheng Y. DNA Repair Pathways in Cancer Therapy and Resistance. Front Pharmacol. 2020;11: 629266.","journal-title":"Front Pharmacol"},{"issue":"1","key":"14082_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12915-020-00771-x","volume":"18","author":"E Clementi","year":"2020","unstructured":"Clementi E, Inglin L, Beebe E, Gsell C, Garajova Z, Markkanen E. Persistent DNA damage triggers activation of the integrated stress response to promote cell survival under nutrient restriction. BMC Biol. 2020;18(1):36.","journal-title":"BMC Biol"},{"key":"14082_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12575-020-00133-5","volume":"22","author":"F Sadeghi","year":"2020","unstructured":"Sadeghi F, Asgari M, Matloubi M, Ranjbar M, Karkhaneh Yousefi N, Azari T, Zaki-Dizaji M. Molecular contribution of BRCA1 and BRCA2 to genome instability in breast cancer patients: review of radiosensitivity assays. Biol Proced Online. 2020;22:23.","journal-title":"Biol Proced Online"},{"issue":"4","key":"14082_CR9","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a016600","volume":"7","author":"R Prakash","year":"2015","unstructured":"Prakash R, Zhang Y, Feng W, Jasin M. Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins. Cold Spring Harb Perspect Biol. 2015;7(4): a016600.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"14082_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nrc3181","volume":"12","author":"R Roy","year":"2011","unstructured":"Roy R, Chun J, Powell SN. BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat Rev Cancer. 2011;12(1):68\u201378.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"14082_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41571-018-0114-z","volume":"16","author":"PG Pilie","year":"2019","unstructured":"Pilie PG, Tang C, Mills GB, Yap TA. State-of-the-art strategies for targeting the DNA damage response in cancer. Nat Rev Clin Oncol. 2019;16(2):81\u2013104.","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"14082_CR12","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1089\/ars.2007.1830","volume":"10","author":"F Altieri","year":"2008","unstructured":"Altieri F, Grillo C, Maceroni M, Chichiarelli S. DNA damage and repair: from molecular mechanisms to health implications. Antioxid Redox Signal. 2008;10(5):891\u2013937.","journal-title":"Antioxid Redox Signal"},{"key":"14082_CR13","doi-asserted-by":"crossref","unstructured":"Stolarova L, Kleiblova P, Janatova M, Soukupova J, Zemankova P, Macurek L, Kleibl Z. CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate. Cells. 2020;9(12):2675.","DOI":"10.3390\/cells9122675"},{"key":"14082_CR14","doi-asserted-by":"crossref","unstructured":"Stucci LS, Interno V, Tucci M, Perrone M, Mannavola F, Palmirotta R, Porta C. The ATM Gene in Breast Cancer: Its Relevance in Clinical Practice. Genes (Basel). 2021;12(5):727.","DOI":"10.3390\/genes12050727"},{"issue":"10","key":"14082_CR15","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1634\/theoncologist.2013-0163","volume":"18","author":"L Santarpia","year":"2013","unstructured":"Santarpia L, Iwamoto T, Di Leo A, Hayashi N, Bottai G, Stampfer M, Andre F, Turner NC, Symmans WF, Hortobagyi GN, et al. DNA repair gene patterns as prognostic and predictive factors in molecular breast cancer subtypes. Oncologist. 2013;18(10):1063\u201373.","journal-title":"Oncologist"},{"key":"14082_CR16","doi-asserted-by":"crossref","unstructured":"Situ Y, Chung L, Lee CS, Ho V. MRN (MRE11-RAD50-NBS1) Complex in Human Cancer and Prognostic Implications in Colorectal Cancer. Int J Mol Sci. 2019;20(4):816.","DOI":"10.3390\/ijms20040816"},{"issue":"1","key":"14082_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41523-021-00350-5","volume":"7","author":"A Alblihy","year":"2021","unstructured":"Alblihy A, Shoqafi A, Toss MS, Algethami M, Harris AE, Jeyapalan JN, Abdel-Fatah T, Servante J, Chan SYT, Green A, et al. Untangling the clinicopathological significance of MRE11-RAD50-NBS1 complex in sporadic breast cancers. NPJ Breast Cancer. 2021;7(1):143.","journal-title":"NPJ Breast Cancer"},{"issue":"2","key":"14082_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrm3047","volume":"12","author":"TH Stracker","year":"2011","unstructured":"Stracker TH, Petrini JH. The MRE11 complex: starting from the ends. Nat Rev Mol Cell Biol. 2011;12(2):90\u2013103.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"14082_CR19","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1080\/07391102.2022.2028678","volume":"41","author":"B Tarapara","year":"2023","unstructured":"Tarapara B, Shah F. An in-silico analysis to identify structural, functional and regulatory role of SNPs in hMRE11. J Biomol Struct Dyn. 2023;41(6):2160\u201374.","journal-title":"J Biomol Struct Dyn"},{"key":"14082_CR20","doi-asserted-by":"crossref","unstructured":"Otahalova B, Volkova Z, Soukupova J, Kleiblova P, Janatova M, Vocka M, Macurek L, Kleibl Z. Importance of Germline and Somatic Alterations in Human MRE11, RAD50, and NBN Genes Coding for MRN Complex. Int J Mol Sci. 2023, 24(6):5612.","DOI":"10.3390\/ijms24065612"},{"issue":"3","key":"14082_CR21","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10549-023-06995-z","volume":"200","author":"M Tufail","year":"2023","unstructured":"Tufail M. DNA repair pathways in breast cancer: from mechanisms to clinical applications. Breast Cancer Res Treat. 2023;200(3):305\u201321.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"14082_CR22","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nrc.2015.21","volume":"16","author":"CJ Lord","year":"2016","unstructured":"Lord CJ, Ashworth A. BRCAness revisited. Nat Rev Cancer. 2016;16(2):110\u201320.","journal-title":"Nat Rev Cancer"},{"key":"14082_CR23","doi-asserted-by":"crossref","unstructured":"Lee JS, Yost SE, Yuan Y. Neoadjuvant Treatment for Triple Negative Breast Cancer: Recent Progresses and Challenges. Cancers (Basel). 2020;12(6):1404.","DOI":"10.3390\/cancers12061404"},{"issue":"3","key":"14082_CR24","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s10549-009-0565-0","volume":"122","author":"JJ Gorski","year":"2010","unstructured":"Gorski JJ, James CR, Quinn JE, Stewart GE, Staunton KC, Buckley NE, McDyer FA, Kennedy RD, Wilson RH, Mullan PB, et al. BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer. Breast Cancer Res Treat. 2010;122(3):721\u201331.","journal-title":"Breast Cancer Res Treat"},{"key":"14082_CR25","doi-asserted-by":"crossref","unstructured":"De Rosa C, Iommelli F, De Rosa V, Ercolano G, Sodano F, Tuccillo C, Amato L, Tirino V, Ariano A, Cimmino F, et al. PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer. Biomedicines. 2024;12(4):809.","DOI":"10.3390\/biomedicines12040809"},{"key":"14082_CR26","unstructured":"Wang Y, Xu X, Maglic D, Dill MT, Mojumdar K, Ng PK, Jeong KJ, Tsang YH, Moreno D, Bhavana VH et al: Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer. Cell Rep.\u00a02018, 25(5):1304\u20131317 e1305."},{"issue":"5","key":"14082_CR27","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1128\/JVI.02495-15","volume":"90","author":"WH Chappell","year":"2015","unstructured":"Chappell WH, Gautam D, Ok ST, Johnson BA, Anacker DC, Moody CA. Homologous Recombination Repair Factors Rad51 and BRCA1 Are Necessary for Productive Replication of Human Papillomavirus 31. J Virol. 2015;90(5):2639\u201352.","journal-title":"J Virol"},{"issue":"1","key":"14082_CR28","first-page":"114","volume":"10","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, Wang Y, Yun D, Huang Q, Meng D, Li Q, Zhang P, Wang C, Chen H, Lu D. TRIM21 overexpression promotes tumor progression by regulating cell proliferation, cell migration and cell senescence in human glioma. Am J Cancer Res. 2020;10(1):114\u201330.","journal-title":"Am J Cancer Res"},{"issue":"7","key":"14082_CR29","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1093\/carcin\/bgq089","volume":"31","author":"S Zhang","year":"2010","unstructured":"Zhang S, Lu J, Zhao X, Wu W, Wang H, Lu J, Wu Q, Chen X, Fan W, Chen H, et al. A variant in the CHEK2 promoter at a methylation site relieves transcriptional repression and confers reduced risk of lung cancer. Carcinogenesis. 2010;31(7):1251\u20138.","journal-title":"Carcinogenesis"},{"key":"14082_CR30","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.3389\/fimmu.2019.02531","volume":"10","author":"J Zhao","year":"2019","unstructured":"Zhao J, Nguyen LNT, Nguyen LN, Dang X, Cao D, Khanal S, Schank M, Thakuri BKC, Ogbu SC, Morrison ZD, et al. ATM Deficiency Accelerates DNA Damage, Telomere Erosion, and Premature T Cell Aging in HIV-Infected Individuals on Antiretroviral Therapy. Front Immunol. 2019;10:2531.","journal-title":"Front Immunol"},{"issue":"3","key":"14082_CR31","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3892\/ol.2015.3411","volume":"10","author":"C Sun","year":"2015","unstructured":"Sun C, Wang Z, Song W, Chen B, Zhang J, Dai X, Wang L, Wu J, Lan Q, Huang Q, et al. Alteration of DNA damage signaling pathway profile in radiation-treated glioblastoma stem-like cells. Oncol Lett. 2015;10(3):1769\u201374.","journal-title":"Oncol Lett"},{"issue":"4","key":"14082_CR32","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/j.1349-7006.2009.01471.x","volume":"101","author":"DS Hsu","year":"2010","unstructured":"Hsu DS, Chang SY, Liu CJ, Tzeng CH, Wu KJ, Kao JY, Yang MH. Identification of increased NBS1 expression as a prognostic marker of squamous cell carcinoma of the oral cavity. Cancer Sci. 2010;101(4):1029\u201337.","journal-title":"Cancer Sci"},{"issue":"4","key":"14082_CR33","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"11","key":"14082_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0294236","volume":"18","author":"D Tang","year":"2023","unstructured":"Tang D, Chen M, Huang X, Zhang G, Zeng L, Zhang G, Wu S, Wang Y. SRplot: A free online platform for data visualization and graphing. PLoS ONE. 2023;18(11): e0294236.","journal-title":"PLoS ONE"},{"issue":"24","key":"14082_CR35","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.21037\/atm-20-2920","volume":"8","author":"M Jiang","year":"2020","unstructured":"Jiang M, Jia K, Wang L, Li W, Chen B, Liu Y, Wang H, Zhao S, He Y, Zhou C. Alterations of DNA damage repair in cancer: from mechanisms to applications. Ann Transl Med. 2020;8(24):1685.","journal-title":"Ann Transl Med"},{"key":"14082_CR36","doi-asserted-by":"crossref","unstructured":"Choi W, Lee ES. Therapeutic Targeting of DNA Damage Response in Cancer. Int J Mol Sci. 2022;23(3):1701.","DOI":"10.3390\/ijms23031701"},{"key":"14082_CR37","doi-asserted-by":"crossref","unstructured":"Ovejero-Sanchez M, Gonzalez-Sarmiento R, Herrero AB. DNA Damage Response Alterations in Ovarian Cancer: From Molecular Mechanisms to Therapeutic Opportunities. Cancers (Basel). 2023;15(2):448.","DOI":"10.3390\/cancers15020448"},{"key":"14082_CR38","doi-asserted-by":"crossref","unstructured":"Raimundo L, Calheiros J, Saraiva L. Exploiting DNA Damage Repair in Precision Cancer Therapy: BRCA1 as a Prime Therapeutic Target. Cancers (Basel). 2021;13(14):3438.","DOI":"10.3390\/cancers13143438"},{"key":"14082_CR39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13578-020-00412-4","volume":"10","author":"Y Liu","year":"2020","unstructured":"Liu Y, Lu LY. BRCA1 and homologous recombination: implications from mouse embryonic development. Cell Biosci. 2020;10:49.","journal-title":"Cell Biosci"},{"issue":"1","key":"14082_CR40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/cr.2008.1","volume":"18","author":"X Li","year":"2008","unstructured":"Li X, Heyer WD. Homologous recombination in DNA repair and DNA damage tolerance. Cell Res. 2008;18(1):99\u2013113.","journal-title":"Cell Res"},{"key":"14082_CR41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fgene.2013.00037","volume":"4","author":"TH Stracker","year":"2013","unstructured":"Stracker TH, Roig I, Knobel PA, Marjanovic M. The ATM signaling network in development and disease. Front Genet. 2013;4:37.","journal-title":"Front Genet"},{"key":"14082_CR42","doi-asserted-by":"crossref","unstructured":"Wang R, Sun Y, Li C, Xue Y, Ba X. Targeting the DNA Damage Response for Cancer Therapy. Int J Mol Sci. 2023;24(21):15907.","DOI":"10.3390\/ijms242115907"},{"key":"14082_CR43","doi-asserted-by":"crossref","unstructured":"Jain A, Barge A, Parris CN. Combination strategies with PARP inhibitors in BRCA-mutated triple-negative breast cancer: overcoming resistance mechanisms. Oncogene. 2025;44:193\u2013207.","DOI":"10.1038\/s41388-024-03227-6"},{"issue":"27","key":"14082_CR44","doi-asserted-by":"publisher","first-page":"9302","DOI":"10.1073\/pnas.0803520105","volume":"105","author":"S Zha","year":"2008","unstructured":"Zha S, Sekiguchi J, Brush JW, Bassing CH, Alt FW. Complementary functions of ATM and H2AX in development and suppression of genomic instability. Proc Natl Acad Sci U S A. 2008;105(27):9302\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"14082_CR45","first-page":"422","volume":"7","author":"NV Panera","year":"2022","unstructured":"Panera NV. Camisa Braghini, Maria Rita Emanuele, Coscia Arnesano, Gabriele Rita, Brugaletta Teresa, Gigliotti Ciabattoni AG, Nucera Lukasz, Szarpak: Perturbation of specific transcripts in peripheral blood mononuclear cells in breast cancer: a case control pilot study. JOURNAL OF HEALTH AND SOCIAL SCIENCES. 2022;7(4):422\u201334.","journal-title":"JOURNAL OF HEALTH AND SOCIAL SCIENCES"},{"key":"14082_CR46","doi-asserted-by":"crossref","unstructured":"Jimenez-Luna C, Gonzalez-Flores E, Ortiz R, Martinez-Gonzalez LJ, Antunez-Rodriguez A, Exposito-Ruiz M, Melguizo C, Caba O, Prados J. Circulating PTGS2, JAG1, GUCY2C and PGF mRNA in Peripheral Blood and Serum as Potential Biomarkers for Patients with Metastatic Colon Cancer. J Clin Med. 2021;10(11):2248.","DOI":"10.3390\/jcm10112248"},{"key":"14082_CR47","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12920-015-0145-6","volume":"8","author":"SR Piccolo","year":"2015","unstructured":"Piccolo SR, Andrulis IL, Cohen AL, Conner T, Moos PJ, Spira AE, Buys SS, Johnson WE, Bild AH. Gene-expression patterns in peripheral blood classify familial breast cancer susceptibility. BMC Med Genomics. 2015;8:72.","journal-title":"BMC Med Genomics"},{"issue":"5","key":"14082_CR48","doi-asserted-by":"publisher","first-page":"R634","DOI":"10.1186\/bcr1203","volume":"7","author":"P Sharma","year":"2005","unstructured":"Sharma P, Sahni NS, Tibshirani R, Skaane P, Urdal P, Berghagen H, Jensen M, Kristiansen L, Moen C, Sharma P, et al. Early detection of breast cancer based on gene-expression patterns in peripheral blood cells. Breast Cancer Res. 2005;7(5):R634\u2013644.","journal-title":"Breast Cancer Res"},{"key":"14082_CR49","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4137\/CIN.S931","volume":"7","author":"ML Vuillaume","year":"2009","unstructured":"Vuillaume ML, Uhrhammer N, Vidal V, Vidal VS, Chabaud V, Jesson B, Kwiatkowski F, Bignon YJ. Use of gene expression profiles of peripheral blood lymphocytes to distinguish BRCA1 mutation carriers in high risk breast cancer families. Cancer Inform. 2009;7:41\u201356.","journal-title":"Cancer Inform"},{"issue":"2","key":"14082_CR50","first-page":"95","volume":"4","author":"M Foroughizadeh","year":"2012","unstructured":"Foroughizadeh M, Mozdarani H, Majidzadeh AK, Kaviani A. Variation of ATM Gene Expression in Peripheral Blood Cells of Sporadic Breast Carcinomas in Iranian Patients. Avicenna J Med Biotechnol. 2012;4(2):95\u2013101.","journal-title":"Avicenna J Med Biotechnol"},{"issue":"10","key":"14082_CR51","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1093\/carcin\/bgi126","volume":"26","author":"J Gu","year":"2005","unstructured":"Gu J, Spitz MR, Zhao H, Lin J, Grossman HB, Dinney CP, Wu X. Roles of tumor suppressor and telomere maintenance genes in cancer and aging\u2013an epidemiological study. Carcinogenesis. 2005;26(10):1741\u20137.","journal-title":"Carcinogenesis"},{"issue":"10","key":"14082_CR52","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1016\/j.apsb.2021.01.003","volume":"11","author":"M Jiang","year":"2021","unstructured":"Jiang M, Jia K, Wang L, Li W, Chen B, Liu Y, Wang H, Zhao S, He Y, Zhou C. Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy. Acta Pharm Sin B. 2021;11(10):2983\u201394.","journal-title":"Acta Pharm Sin B"},{"issue":"6","key":"14082_CR53","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.hoc.2018.07.006","volume":"32","author":"PA Konstantinopoulos","year":"2018","unstructured":"Konstantinopoulos PA, Matulonis UA. Targeting DNA Damage Response and Repair as a Therapeutic Strategy for Ovarian Cancer. Hematol Oncol Clin North Am. 2018;32(6):997\u20131010.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"14082_CR54","first-page":"147","volume":"10","author":"AN Zghair","year":"2018","unstructured":"Zghair AN, Sharma R, Alfaham M, Sharma AK. Upregulation of, and marker genes expression in breast cancer patients. International Journal of Pharmaceutical Research. 2018;10(2):147.","journal-title":"International Journal of Pharmaceutical Research"},{"issue":"6","key":"14082_CR55","first-page":"3542","volume":"42","author":"Z Wang","year":"2018","unstructured":"Wang Z, Zhang J, Zhang Y, Deng Q, Liang H. Expression and mutations of BRCA in breast cancer and ovarian cancer: Evidence from bioinformatics analyses. Int J Mol Med. 2018;42(6):3542\u201350.","journal-title":"Int J Mol Med"},{"issue":"6","key":"14082_CR56","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/s41416-018-0217-4","volume":"119","author":"I Tsibulak","year":"2018","unstructured":"Tsibulak I, Wieser V, Degasper C, Shivalingaiah G, Wenzel S, Sprung S, Lax SF, Marth C, Fiegl H, Zeimet AG. BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer. Br J Cancer. 2018;119(6):683\u201392.","journal-title":"Br J Cancer"},{"issue":"9","key":"14082_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137972","volume":"10","author":"J Panero","year":"2015","unstructured":"Panero J, Stella F, Schutz N, Fantl DB, Slavutsky I. Differential Expression of Non-Shelterin Genes Associated with High Telomerase Levels and Telomere Shortening in Plasma Cell Disorders. PLoS ONE. 2015;10(9): e0137972.","journal-title":"PLoS ONE"},{"issue":"7","key":"14082_CR58","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/gcc.22171","volume":"53","author":"M Hoxha","year":"2014","unstructured":"Hoxha M, Fabris S, Agnelli L, Bollati V, Cutrona G, Matis S, Recchia AG, Gentile M, Cortelezzi A, Morabito F, et al. Relevance of telomere\/telomerase system impairment in early stage chronic lymphocytic leukemia. Genes Chromosomes Cancer. 2014;53(7):612\u201321.","journal-title":"Genes Chromosomes Cancer"},{"key":"14082_CR59","doi-asserted-by":"crossref","unstructured":"Poncet D, Belleville A, t'kint de Roodenbeke C, Roborel de Climens A, Ben Simon E, Merle-Beral H, Callet-Bauchu E, Salles G, Sabatier L, Delic J et al: Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia. Blood. 2008, 111(4):2388\u20132391.","DOI":"10.1182\/blood-2007-09-111245"},{"issue":"3","key":"14082_CR60","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.molcel.2016.10.011","volume":"64","author":"NN Hoa","year":"2016","unstructured":"Hoa NN, Shimizu T, Zhou ZW, Wang ZQ, Deshpande RA, Paull TT, Akter S, Tsuda M, Furuta R, Tsutsui K, et al. Mre11 Is Essential for the Removal of Lethal Topoisomerase 2 Covalent Cleavage Complexes. Mol Cell. 2016;64(3):580\u201392.","journal-title":"Mol Cell"},{"issue":"6","key":"14082_CR61","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/bjc.2015.60","volume":"112","author":"S Rondeau","year":"2015","unstructured":"Rondeau S, Vacher S, De Koning L, Briaux A, Schnitzler A, Chemlali W, Callens C, Lidereau R, Bieche I. ATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levels. Br J Cancer. 2015;112(6):1059\u201366.","journal-title":"Br J Cancer"},{"issue":"1","key":"14082_CR62","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10549-009-0499-6","volume":"119","author":"JJ de Ronde","year":"2010","unstructured":"de Ronde JJ, Hannemann J, Halfwerk H, Mulder L, Straver ME, Vrancken Peeters MJ, Wesseling J, van de Vijver M, Wessels LF, Rodenhuis S. Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response. Breast Cancer Res Treat. 2010;119(1):119\u201326.","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"14082_CR63","first-page":"7825","volume":"14","author":"H Xiong","year":"2017","unstructured":"Xiong H, Zhang J. Expression and clinical significance of ATM and PUMA gene in patients with colorectal cancer. Oncol Lett. 2017;14(6):7825\u20138.","journal-title":"Oncol Lett"},{"issue":"1","key":"14082_CR64","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13046-019-1161-8","volume":"38","author":"M Shen","year":"2019","unstructured":"Shen M, Xu Z, Xu W, Jiang K, Zhang F, Ding Q, Xu Z, Chen Y. Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK\/STAT3\/PD-L1 pathway. J Exp Clin Cancer Res. 2019;38(1):149.","journal-title":"J Exp Clin Cancer Res"},{"key":"14082_CR65","doi-asserted-by":"crossref","unstructured":"Santana Dos Santos E, Lallemand F, Petitalot A, Caputo SM, Rouleau E. HRness in Breast and Ovarian Cancers. Int J Mol Sci. 2020;21(11):3850.","DOI":"10.3390\/ijms21113850"},{"key":"14082_CR66","first-page":"9","volume":"2018","author":"GA Foulds","year":"2028","unstructured":"Foulds GA, Vadakekolathu J, Abdel-Fatah TMA, Nagarajan D, Reeder S, Johnson C, Hood S, Moseley PM, Chan SYT, Pockley AG, et al. Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts Relapse of Triple Negative Breast Cancer. Front Immunol. 2028;2018:9.","journal-title":"Front Immunol"},{"issue":"12","key":"14082_CR67","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nri.2016.99","volume":"16","author":"C Munoz-Fontela","year":"2016","unstructured":"Munoz-Fontela C, Mandinova A, Aaronson SA, Lee SW. Emerging roles of p53 and other tumour-suppressor genes in immune regulation. Nat Rev Immunol. 2016;16(12):741\u201350.","journal-title":"Nat Rev Immunol"},{"key":"14082_CR68","doi-asserted-by":"crossref","unstructured":"Aktar S, Hamid FB, Gamage SMK, Cheng T, Parkneshan N, Lu CT, Islam F, Gopalan V, Lam AK. Gene Expression Analysis of Immune Regulatory Genes in Circulating Tumour Cells and Peripheral Blood Mononuclear Cells in Patients with Colorectal Carcinoma. Int J Mol Sci. 2023;24(5):5051.","DOI":"10.3390\/ijms24055051"},{"issue":"5","key":"14082_CR69","doi-asserted-by":"publisher","first-page":"489","DOI":"10.4161\/cbt.28016","volume":"15","author":"AY Liu","year":"2014","unstructured":"Liu AY, Liu DG, Du YJ, Pei FH, Yang G, Liu BR, Zhang HT, Wang XH, Fan YJ, Chen YZ, et al. Relationship between tumor and peripheral blood NPRL2 mRNA levels in patients with colorectal adenoma and colorectal cancer. Cancer Biol Ther. 2014;15(5):489\u201395.","journal-title":"Cancer Biol Ther"},{"key":"14082_CR70","doi-asserted-by":"crossref","unstructured":"Kurian AW, Abrahamse P, Ward KC, Hamilton AS, Deapen D, Berek JS, Hoang L, Yussuf A, Dolinsky J, Brown K et al. Association of Family Cancer History With Pathogenic Variants in Specific Breast Cancer Susceptibility Genes. JCO Precis Oncol. 2021;5:PO.21.00261.","DOI":"10.1200\/PO.21.00261"},{"issue":"30","key":"14082_CR71","doi-asserted-by":"publisher","first-page":"7503","DOI":"10.1200\/JCO.2005.01.3698","volume":"23","author":"E Honrado","year":"2005","unstructured":"Honrado E, Osorio A, Palacios J, Milne RL, Sanchez L, Diez O, Cazorla A, Syrjakoski K, Huntsman D, Heikkila P, et al. Immunohistochemical expression of DNA repair proteins in familial breast cancer differentiate BRCA2-associated tumors. J Clin Oncol. 2005;23(30):7503\u201311.","journal-title":"J Clin Oncol"},{"issue":"1","key":"14082_CR72","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ygyno.2016.01.004","volume":"141","author":"M Zhang","year":"2016","unstructured":"Zhang M, Liu G, Xue F, Edwards R, Sood AK, Zhang W, Yang D. Copy number deletion of RAD50 as predictive marker of BRCAness and PARP inhibitor response in BRCA wild type ovarian cancer. Gynecol Oncol. 2016;141(1):57\u201364.","journal-title":"Gynecol Oncol"},{"issue":"9","key":"14082_CR73","first-page":"2643","volume":"19","author":"WA Harahap","year":"2018","unstructured":"Harahap WA, Sudji IR, Nindrea RD. BRCA1 Promoter Methylation and Clinicopathological Characteristics in Sporadic Breast Cancer Patients in Indonesia. Asian Pac J Cancer Prev. 2018;19(9):2643\u20139.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"14082_CR74","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41580-020-0218-z","volume":"21","author":"M Tarsounas","year":"2020","unstructured":"Tarsounas M, Sung P. The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication. Nat Rev Mol Cell Biol. 2020;21(5):284\u201399.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"14082_CR75","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3892\/ol.2021.12485","volume":"21","author":"O Ge","year":"2021","unstructured":"Ge O, Huang A, Wang X, Chen Y, Ye Y, Schomburg L. PALB2 upregulation is associated with a poor prognosis in pancreatic ductal adenocarcinoma. Oncol Lett. 2021;21(3):224.","journal-title":"Oncol Lett"},{"issue":"2","key":"14082_CR76","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.18632\/aging.205366","volume":"16","author":"L Li","year":"2024","unstructured":"Li L, Li S, Zhang X, Mei L, Fu X, Dai M, Wei N. Establishing the role of BRCA1 in the diagnosis, prognosis and immune infiltrates of breast invasive cancer by bioinformatics analysis and experimental validation. Aging (Albany NY). 2024;16(2):1077\u201395.","journal-title":"Aging (Albany NY)"},{"key":"14082_CR77","first-page":"2563910","volume":"2017","author":"CH Yang","year":"2017","unstructured":"Yang CH, Moi SH, Chuang LY, Yuan SF, Hou MF, Lee YC, Chang HW. Interaction of MRE11 and Clinicopathologic Characteristics in Recurrence of Breast Cancer: Individual and Cumulated Receiver Operating Characteristic Analyses. Biomed Res Int. 2017;2017:2563910.","journal-title":"Biomed Res Int"},{"issue":"10","key":"14082_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108483","volume":"9","author":"T Pavelitz","year":"2014","unstructured":"Pavelitz T, Renfro L, Foster NR, Caracol A, Welsch P, Lao VV, Grady WB, Niedzwiecki D, Saltz LB, Bertagnolli MM, et al. MRE11-deficiency associated with improved long-term disease free survival and overall survival in a subset of stage III colon cancer patients in randomized CALGB 89803 trial. PLoS ONE. 2014;9(10): e108483.","journal-title":"PLoS ONE"},{"key":"14082_CR79","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/B978-0-12-411638-2.00002-1","volume":"124","author":"S Chatterjee","year":"2014","unstructured":"Chatterjee S, Behnam Azad B, Nimmagadda S. The intricate role of CXCR4 in cancer. Adv Cancer Res. 2014;124:31\u201382.","journal-title":"Adv Cancer Res"},{"issue":"6","key":"14082_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100041","volume":"9","author":"R Koppensteiner","year":"2014","unstructured":"Koppensteiner R, Samartzis EP, Noske A, von Teichman A, Dedes I, Gwerder M, Imesch P, Ikenberg K, Moch H, Fink D, et al. Effect of MRE11 loss on PARP-inhibitor sensitivity in endometrial cancer in vitro. PLoS ONE. 2014;9(6): e100041.","journal-title":"PLoS ONE"},{"key":"14082_CR81","doi-asserted-by":"crossref","unstructured":"Ho V, Chung L, Wilkinson K, Lea V, Lim SH, Abubakar A, Ng W, Lee M, Roberts TL, Chua W et al. Prognostic Significance of MRE11 Overexpression in Colorectal Cancer Patients. Cancers (Basel). 2023;15(9):2438.","DOI":"10.3390\/cancers15092438"},{"issue":"10","key":"14082_CR82","doi-asserted-by":"publisher","first-page":"5237","DOI":"10.21873\/anticanres.11094","volume":"36","author":"B Altan","year":"2016","unstructured":"Altan B, Yokobori T, Ide M, Bai T, Yanoma T, Kimura A, Kogure N, Suzuki M, Bao P, Mochiki E, et al. High Expression of MRE11-RAD50-NBS1 Is Associated with Poor Prognosis and Chemoresistance in Gastric Cancer. Anticancer Res. 2016;36(10):5237\u201347.","journal-title":"Anticancer Res"},{"issue":"18","key":"14082_CR83","doi-asserted-by":"publisher","first-page":"7017","DOI":"10.1158\/0008-5472.CAN-10-1202","volume":"70","author":"A Choudhury","year":"2010","unstructured":"Choudhury A, Nelson LD, Teo MT, Chilka S, Bhattarai S, Johnston CF, Elliott F, Lowery J, Taylor CF, Churchman M, et al. MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer. Cancer Res. 2010;70(18):7017\u201326.","journal-title":"Cancer Res"},{"issue":"1","key":"14082_CR84","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41416-021-01295-z","volume":"125","author":"PM Morice","year":"2021","unstructured":"Morice PM, Coquan E, Weiswald LB, Lambert B, Vaur D, Poulain L. Identifying patients eligible for PARP inhibitor treatment: from NGS-based tests to 3D functional assays. Br J Cancer. 2021;125(1):7\u201314.","journal-title":"Br J Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14082-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14082-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14082-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T17:02:56Z","timestamp":1744218176000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14082-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14082"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14082-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"9 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by The Institutional Review Board Committee (IRB) of The Gujarat Cancer & Research Institute (EC\/BHR\/10\/2022) and was conducted in accordance with the Declaration of Helsinki. Informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"650"}}